Cancer Family
Pancreaticobiliary Neoplasm
CI-CAN-00000309Explore in graph →
Non-malignant1,205 active trials11 approved drugs92 evidence items
- NCIt
- C223357
Loading cancer entity…
Cancer Family
CI-CAN-00000309Explore in graph →
Clinical trials
5,005 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03261947 | A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors | completed | Phase 2 | 101 | Millennium Pharmaceuticals, Inc.INDUSTRY | 2 | Sep 20, 2021 | clinicaltrials |
| NCT03041662 | Surveillance Study for Early Detection of Cholangiocarcinoma (CCA) in Primary Sclerosing Cholangitis (PSC)(PSC) | completed | — | 620 | Karolinska University HospitalOTHER |
| 1 |
| Sep 16, 2021 |
| clinicaltrials |
| NCT00010166 | Gemcitabine and Radiation Therapy in Treating Patients With Cancer of the Pancreas | completed | Phase 2 | 26 | Wake Forest University Health SciencesOTHER | 1 | Sep 9, 2021 | clinicaltrials |
| NCT00025168 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer | completed | Phase 2 | 20 | Wake Forest University Health SciencesOTHER | 1 | Sep 9, 2021 | clinicaltrials |
| NCT02343835 | Anti-Tumor Immunity Induced by IRE of Unresectable Pancreatic Cancer | completed | N/A | 20 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Sep 5, 2021 | clinicaltrials |
| NCT02430662 | Irreversible Electroporation(IRE) For Unresectable Gallbladder Neoplasms(IRE) | completed | N/A | 30 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Sep 5, 2021 | clinicaltrials |
| NCT02777710 | Evaluation of Safety and Activity of an Anti-PDL1 Antibody (DURVALUMAB) Combined With CSF-1R TKI (PEXIDARTINIB) in Patients With Metastatic/Advanced Pancreatic or Colorectal Cancers(MEDIPLEX) | completed | Phase 1 | 48 | Centre Leon BerardOTHER | 1 | Sep 5, 2021 | clinicaltrials |
| NCT04301999 | Clinical Effect and Safety of PDT and RFA for Unresectable EHCC | completed | N/A | 67 | First People's Hospital of HangzhouOTHER | 1 | Sep 1, 2021 | clinicaltrials |
| NCT04310111 | EUS-RFA for Unresectable Pancreatic Cancer | completed | N/A | 8 | First People's Hospital of HangzhouOTHER | 1 | Aug 30, 2021 | clinicaltrials |
| NCT00041639 | Safety Study of 90Y-hMN14 to Treat Pancreatic Cancer | completed | Phase 1 / Phase 2 | 75 | Gilead SciencesINDUSTRY | 4 | Aug 19, 2021 | clinicaltrials |
| NCT00597129 | Safety and Efficacy Study of 90Y-hPAM4 at Different Doses | completed | Phase 1 / Phase 2 | 21 | Gilead SciencesINDUSTRY | 1 | Aug 19, 2021 | clinicaltrials |
| NCT05012540 | SII And PALBI is Associated With the Prognosis of Pancreatic Cancer Surgery(SII,PALBI)(SII) | completed | — | 214 | The Affiliated Hospital of Qingdao UniversityOTHER | 0 | Aug 19, 2021 | clinicaltrials |
| NCT02138383 | Enzalutamide in Combination With Gemcitabine and Nab-Paclitaxel for the Treatment of Advanced Pancreatic Cancer | completed | Phase 1 | 25 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Aug 17, 2021 | clinicaltrials |
| NCT02250638 | Longitudinal Pancreatic Cancer Study | completed | — | 140 | Fujirebio Diagnostics, Inc.INDUSTRY | 2 | Aug 17, 2021 | clinicaltrials |
| NCT00603863 | Safety and Efficacy Study of Different Doses of 90Y-hPAM4 Combined With Gemcitabine in Pancreatic Cancer | completed | Phase 1 / Phase 2 | 80 | Gilead SciencesINDUSTRY | 1 | Aug 16, 2021 | clinicaltrials |
| NCT04293497 | Development of a New Immunochemistry Method Using Antibodies of Proteins Related Pancreatic Cancer | completed | N/A | 97 | Gangnam Severance HospitalOTHER | 1 | Aug 13, 2021 | clinicaltrials |
| NCT01631552 | Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer | completed | Phase 1 / Phase 2 | 515 | Gilead SciencesINDUSTRY | 1 | Aug 12, 2021 | clinicaltrials |
| NCT02807844 | Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies | completed | Phase 1 / Phase 2 | 141 | Novartis PharmaceuticalsINDUSTRY | 11 | Aug 11, 2021 | clinicaltrials |
| NCT01666730 | Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer | completed | Phase 2 | 50 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 10, 2021 | clinicaltrials |
| NCT02812992 | Geriatric Assessment Directed Trial to Evaluate Gemcitabine +/- Nab-paclitaxel in Elderly Pancreatic Cancer Patients(GrantPax) | completed | Phase 4 | 32 | AIO-Studien-gGmbHOTHER | 1 | Aug 10, 2021 | clinicaltrials |
| NCT01465659 | Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery | completed | Phase 1 / Phase 2 | 29 | Northwestern UniversityOTHER | 1 | Aug 5, 2021 | clinicaltrials |
| NCT02631590 | Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma | completed | Phase 2 | 24 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Aug 4, 2021 | clinicaltrials |
| NCT03316599 | Study of Gemcitabine, Nab-paclitaxel, and Ficlatuzumab (AV-299) in Patients With Advanced Pancreatic Cancer | completed | Phase 1 | 26 | Dana-Farber Cancer InstituteOTHER | 1 | Aug 3, 2021 | clinicaltrials |
| NCT04977596 | Related Studies of Imaging Features and Prognosis Between Pancreatic Neuroendocrine Tumors and Pancreatic Cancer | completed | — | 78 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jul 27, 2021 | clinicaltrials |
| NCT02546531 | Defactinib Combined With Pembrolizumab and Gemcitabine in Patients With Advanced Cancer | completed | Phase 1 | 43 | Washington University School of MedicineOTHER | 1 | Jul 20, 2021 | clinicaltrials |
| NCT03003078 | A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine+Abraxane(PanCO) | completed | N/A | 50 | OncoSil Medical LimitedINDUSTRY | 3 | Jul 13, 2021 | clinicaltrials |
| NCT03076216 | A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With Gemcitabine +/- Nab-paclitaxel.(OncoPaC-1) | completed | N/A | 9 | OncoSil Medical LimitedINDUSTRY | 1 | Jul 13, 2021 | clinicaltrials |
| NCT04420039 | Plastic Stent Within a Lumen-Apposing Stent for Malignant Biliary Obstruction(LAMSpigBil) | completed | — | 39 | Hospital Universitari de BellvitgeOTHER | 1 | Jul 13, 2021 | clinicaltrials |
| NCT04954378 | Radiomics Based on Multimodal Imaging in Predicting Staging and Prognosis of Pancreatic Cancer | completed | — | 300 | Peking University Third HospitalOTHER | 0 | Jul 8, 2021 | clinicaltrials |
| NCT01104077 | Family and Personal History of Malignancy in Intraductal Papillary Mucinous Neoplasm (IPMN) | completed | — | 277 | Columbia UniversityOTHER | 1 | Jul 6, 2021 | clinicaltrials |
| NCT02550327 | Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer | completed | Early Phase 1 | 20 | Baylor Research InstituteOTHER | 1 | Jun 22, 2021 | clinicaltrials |
| NCT00438906 | Cancer of the Pancreas Screening Study (CAPS 3)(CAPS 3) | completed | — | 200 | Johns Hopkins UniversityOTHER | 1 | Jun 18, 2021 | clinicaltrials |
| NCT03189953 | 68Ga-NODAGA-exendin-4 PET/CT for Diagnostic Imaging in AHH(GLP-1-AHH) | completed | Phase 1 / Phase 2 | 56 | Radboud University Medical CenterOTHER | 0 | Jun 16, 2021 | clinicaltrials |
| NCT03188991 | Intracystic Injection of NanoPac® in Subjects With Mucinous Cystic Pancreatic Neoplasms | completed | Phase 2 | 20 | NanOlogy, LLCINDUSTRY | 1 | Jun 14, 2021 | clinicaltrials |
| NCT00031694 | Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer | completed | Phase 2 | 19 | National Cancer Institute (NCI)NIH | 1 | Jun 11, 2021 | clinicaltrials |
| NCT01219829 | Pancreatic Intraepithelial Neoplasia (PanIN) and the Association With Recurrence of Pancreatic Adenocarcinoma | completed | — | 5 | Columbia UniversityOTHER | 1 | Jun 11, 2021 | clinicaltrials |
| NCT01027221 | Low Dose Radiation to Improve T-Cell Infiltration in Pancreatic Cancer(IMPACT2010) | completed | N/A | 32 | German Cancer Research CenterOTHER | 1 | Jun 10, 2021 | clinicaltrials |
| NCT04656249 | Lenvatinib in Patients With Previously Treated Advanced Biliary Tract Cancer(LENABC) | completed | Phase 2 | 46 | Peking Union Medical College HospitalOTHER | 1 | Jun 4, 2021 | clinicaltrials |
| NCT04642664 | Apatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer(ACABC) | completed | Phase 2 | 22 | Peking Union Medical College HospitalOTHER | 1 | Jun 3, 2021 | clinicaltrials |
| NCT02368860 | OXIRI [Oxaliplatin (O), Xeloda (X) and Irinotecan (I)] in Pancreatic Adenocarcinoma(OXIRI) | completed | Phase 1 | 33 | National Cancer Centre, SingaporeOTHER | 1 | Jun 1, 2021 | clinicaltrials |
| NCT04724551 | The Neutrophil-to-Lymphocyte Ratio to Exclude Pancreatic Fistula(NLR) | completed | — | 648 | Institut Paoli-CalmettesOTHER | 0 | May 28, 2021 | clinicaltrials |
| NCT03599154 | Evaluation of GEMCITEST in Patients With Pancreatic Cancer and Treated by Chemotherapy(GEMCIPANC) | completed | — | 100 | Centre Georges Francois LeclercOTHER | 1 | May 24, 2021 | clinicaltrials |
| NCT03062124 | SpyGlass in Preoperative Diagnostics of Presumed Main Duct IPMNs: Efficacy and Novel Insights on Complications | completed | — | 101 | Helsinki University Central HospitalOTHER | 2 | May 20, 2021 | clinicaltrials |
| NCT01459614 | Gemcitabine/Taxotere/Xeloda (GTX) With Cisplatin in Subjects With Metastatic Pancreatic Cancer | completed | Phase 2 | 44 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | May 19, 2021 | clinicaltrials |
| NCT04509492 | Role of EUS in Detection of Liver Metastasis | completed | — | 400 | Mahmoud WahbaOTHER | 1 | May 18, 2021 | clinicaltrials |
| NCT02716207 | Phase ǀ Study on Pancreatic Cancer Treated by CyberKnife | completed | N/A | 16 | Changhai HospitalOTHER | 1 | May 14, 2021 | clinicaltrials |
| NCT04660695 | Nasobiliary Drain Assisted EUS-guided Gastroenterostomies in Unresectable Malignant Gastric Outlet Obstruction(PENGUIN) | completed | — | 66 | Hospital del Rio HortegaOTHER | 2 | May 14, 2021 | clinicaltrials |
| NCT02237157 | A Dose Escalation Safety Study of Locally-Delivered Gemcitabine in Pancreatic Cancer | completed | Phase 1 | 20 | RenovoRxINDUSTRY | 1 | May 7, 2021 | clinicaltrials |
| NCT02562898 | Ibrutinib Combined With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer | completed | Phase 1 / Phase 2 | 18 | Margaret TemperoOTHER | 1 | May 6, 2021 | clinicaltrials |
| NCT03205176 | AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas | completed | Phase 1 | 49 | AstraZenecaINDUSTRY | 2 | May 6, 2021 | clinicaltrials |
Data updated 23 days agoSource updated Sep 20, 2021source: clinicaltrials